כללית שלי
Departments
Appointment Center Contact Us

Contact information

Telephone:
03-9377250/77
Internal Medicine D Department:
03-9376751

Fax:
03-9377261

Location

​Ambulatory Clinics Building, Beilinson Hospital, 2nd floor

Liver Institute - Beilinson

Dr. Marius Brown

​About the Institute

Physicians of the Institute diagnose and treat patients with acute and chronic liver diseases, viral diseases, fatty liver, metabolic diseases, immune diseases, liver diseases caused by alcohol drinking and medications, liver cirrhosis and its complications, and liver cancer.
The institute has a unique unit for liver transplantees, in the unit patients are evaluated before they undergo  liver transplantation and are monitore after the  transplantation.

FIBROSCAN - Noninvasive testing to evaluate the severity of a liver disease

Beilinson Hospital's liver diseases institute utilized a state-of-the-art device - digital Fibroscan.
This device is use to evaluate the extent of liver fibrosis, using a method much similar to ultrasound testing, i.e, in a non-invasive and painless manner.
The most important prognostic indicator in liver disease is fibrosis, and its severity is what serves to make appropriate treatment decisions.
The device enables an evaluation of fibrosis to be performed in hepatitis C, fatty liver disease, hepatitis B, cholestatic diseases and other liver diseases.

Patients with a chronic liver disease initially suffer from liver infection, which in some cases becomes a fibrosis. Without treatment the severity of the fibrosis might lead to disruption in the blood flow through the liver and decreased liver function, all of which severely affect the quality of life. The patient, and might shorten the patient's life expectancy.
The most important indication of the severity of a liver disease, and the risk of its deterioration, is the degree of liver fibrosis. 
Therefore, it is very important to assess the presence of liver fibrosis in all liver patients, regardless of the cause of their disease, and to quantify its intensity.
Until now, in order to determine the severity of the disease, it was necessary to perform liver biopsies that require hospitalization.
Today, a relatively new test - elastography (performed using the Fibroscan® device) - determines the extent of the fibrosis, asseses whether there is any liver damage, and how severe the damage is, without the need for any invasive operations.

The examination can be performed in the Beilinson Liver Disease Institute on receipt of a "commitment" form (service code 69012) or self-financing.
The examination is included in the "basket" of services for patients with hepatitis C prior to treatment.

In your application please indicate the type of disease and liver functions.

Academic and research activities

The Institutes's scientific research focuses on hepatitis viruses and the searche for new treatments for hepatitis C. We also conduct studies that investigate ways to reduce liver damage caused by liver surgery and liver transplantation. Clinical studies relating to the entire range of treatment for liver diseases, such as viral hepatitis, fatty liver and liver cancer, are all carried out in the institute.

Preparation for selected procedures

Liver biopsies - through the skin and jugula

r vein, abdominal punctures, insertion of inner-liver bypass through the neck, expansion of bile ducts stenosis.

Application method:
Referral by an attending physician

Days and hours of activity

Sunday to Thursday from 08:00 to 15:30